公开(公告)号：EP4364734A1

公开(公告)日：2024-05-08

申请号：EP22833577.4

申请日：2022-06-28

申请人： Kyongbo Pharm. Co., Ltd. ,  Ndic Co., Ltd.

发明人： HAN, Jeong Seok ,  PARK, Yong Kyu ,  BANG, Sung Hun ,  KIM, Jae Hyun ,  JANG, Ha Lim ,  KIM, Ye Rin ,  LEE, Su Kyoung ,  LIM, Taek Joo

IPC分类号： A61K31/4166 ,  A61P13/12 ,  A23K20/137

CPC分类号： A23K20/137 ,  A61P13/12 ,  A61K31/4166

摘要： Disclosed are a pharmaceutical composition for animals containing 5-hydroxy-1-methylimidazolidine-2,4-dione as an active ingredient, more specifically, a composition for preventing or treating kidney disease in animals containing 5-hydroxy-1-methylimidazolidine-2,4-dione or a pharmaceutically acceptable salt thereof as an active ingredient, a method of treating kidney disease in animals using the compound, and a functional feed for preventing or ameliorating kidney disease in animals containing the compound as an active ingredient. The 5-hydroxy-1-methylimidazolidine-2,4-dione can effectively ameliorate and treat symptoms of kidney disease when administered to companion animals such as dogs or cats with kidney disease. Therefore, there are provided a novel agent and method for treating kidney disease of animals that can effectively treat kidney disease, which is the cause of high mortality in companion animals.